Postfinance is expanding the range of cryptocurrencies that can be traded via E-Finance or the PostFinance App. The number ...

Zurich Insurance Group achieved record figures for both profit and adjusted return on equity. In particular, the property and ...

The Swiss financial regulator is relocating its Zurich offices to Oerlikon. It will move into a building owned by the ...

Ricardo Castillo took over as Head of Investments at Mirabaud Wealth Management and CIO for Mirabaud Group in the summer of last year. He spoke with finews about the Federal Reserve, the US and EU ...

With the Young Generation Art Award, Degussa promotes emerging artistic talent. In 2026, Nigerian painter Ken Nwadiogbu wins the prize — along with prize money, an exhibition, and an international ...

Technology, automation, and AI have made the financial industry more efficient—but not more trusted. What hospitality and finance have in common, and why empathy, service ethics, and integrity are ...

A record year for structured products: 235 billion francs in turnover, strong demand for leveraged and yield-enhancement products — and optimistic prospects for 2026.

Amid the geopolitical turmoil, uncertainty on tariffs and supply chain disruptions, ING systematically doubling down to support its clients and Swiss corporates. And it has ambitious goals.

Following strong earnings momentum in the fourth quarter of 2025, BB Biotech’s management is looking confidently at the year ahead.

As an airline, we must constantly reinvent ourselves to delight our customers,» Armelle Comte says in an interview with finews. Artificial intelligence now clearly lies at the heart of this innovation ...

The B2B transaction bank has appointed a new Head of Corporate Services, who will also join the Executive Board as its fourth member.

BB Biotech has benefited from stabilised market conditions. Over the past year, investors have once again focused more strongly on company-specific fundamentals.